Table 1

Details of nodules and associated clinical data

Cancer, n (%)Benign, n (%)Total (%)
Patient sex, counted by nodule
 Male92 (39.3)624 (53.7)716 (51.3)
 Female142 (60.7)539 (46.3)681 (48.7)
Nodule size (clinician-stated)
 5 mm8 (3.4)268 (23.0)276 (19.8)
 >5 to ≤7 mm17 (7.3)438 (37.7)455 (32.6)
 >7 to ≤10 mm59 (25.2)294 (25.3)353 (25.3)
 >10 to ≤15 mm150 (64.1)163 (14.0)313 (22.4)
Patient age (years), by nodule
 0–497 (3.0)151 (13.0)158 (11.3)
 50–5927 (11.5)201 (17.3)228 (16.3)
 60–6985 (36.3)359 (30.9)444 (31.8)
 70–7991 (38.9)320 (27.5)411 (29.4)
 80–8923 (9.8)126 (10.8)149 (10.7)
 90–991 (0.4)5 (0.4)6 (0.4)
Nodule contrast (autodetected)
 0 to ≤80 HU104 (44.4)581 (50.0)685 (49.0)
 80 to ≤300 HU130 (55.6)582 (50.0)712 (51.0)
Nodule locations
 Right upper lobe83 (35.5)235 (20.2)318 (22.8)
 Right middle lobe12 (5.1)185 (15.9)197 (14.1)
 Right lower lobe36 (15.4)309 (26.6)345 (24.7)
 Left upper lobe51 (21.8)159 (13.7)210 (15.0)
 Lingula lobe6 (2.6)37 (3.2)43 (3.1)
 Left lower lobe46 (19.7)238 (20.5)284 (20.3)
Nodule spiculation
 Non-spiculated96 (41.0)993 (85.4)1089 (78.0)
 Spiculated138 (59.0)170 (14.6)308 (22.0)
Centres by nodule
 Leeds89 (20.3)349 (79.7)438 (31.4)
 Nottingham93 (22.0)330 (78.0)423 (30.3)
 Oxford52 (9.7)484 (90.3)536 (38.4)
  • “Oxford” includes data contributions from Reading and Frimley hospitals, overseen by clinicians from the central OUH site.